We are live on ! Find out more
TSS

Thomas Story & Son Portfolio holdings

AUM $283M
1-Year Est. Return 40%
This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+40%
3 Year Est. Return
+91.81%
5 Year Est. Return
+109.54%
10 Year Est. Return
+394.03%
AUM
$162M
AUM Growth
-$21.3M
Cap. Flow
-$26.5M
Cap. Flow %
-16.34%
Top 10 Hldgs %
45.97%
Holding
63
New
1
Increased
1
Reduced
23
Closed
7

Top Buys

Rank Stock Value
1
GNTX icon
Gentex
GNTX
+$1.55M
2
BWP
Boardwalk Pipeline Partners
BWP
+$232K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$2.23M
2
PX
Praxair Inc
PX
+$2.08M
3
FAST icon
Fastenal
FAST
+$1.88M
4
CLR
CONTINENTAL RESOURCES INC.
CLR
+$1.83M
5
V icon
Visa
V
+$1.82M

Sector Composition

Rank Sector Weight
1 Industrials 17.78%
2 Energy 16.29%
3 Technology 12.44%
4 Healthcare 12.31%
5 Financials 11.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLNX
26
DELISTED
Xilinx Inc
XLNX
$2.14M 1.32%
45,147
– –
TDC icon
27
Teradata
TDC
$2.92B
$2.03M 1.25%
50,500
-13,950
-22% -$609K
APO icon
28
Apollo Global Management
APO
$72.4B
$1.79M 1.1%
64,465
– –
SIAL
29
DELISTED
SIGMA - ALDRICH CORP
SIAL
$1.67M 1.03%
16,500
– –
SYNT
30
DELISTED
Syntel Inc
SYNT
$1.56M 0.96%
36,420
-13,600
-27% -$560K
SPLS
31
DELISTED
Staples Inc
SPLS
$1.54M 0.95%
142,405
– –
BXMT icon
32
Blackstone Mortgage Trust
BXMT
$2.45B
$1.47M 0.9%
50,600
– –
MCD icon
33
McDonald's
MCD
$192B
$1.4M 0.86%
13,910
-2,354
-14% -$238K
AMGN icon
34
Amgen
AMGN
$208B
$1.11M 0.68%
9,357
– –
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.1M 0.68%
8,674
– –
EMR icon
36
Emerson Electric
EMR
$83.9B
$1.09M 0.67%
16,400
– –
D icon
37
Dominion Energy
D
$60.8B
$994K 0.61%
13,903
– –
PX
38
DELISTED
Praxair Inc
PX
$969K 0.6%
7,296
-15,900
-69% -$2.08M
CAT icon
39
Caterpillar
CAT
$375B
$913K 0.56%
8,400
– –
DO
40
DELISTED
Diamond Offshore Drilling
DO
$908K 0.56%
18,294
-300
-2% -$14.9K
SCG
41
DELISTED
Scana
SCG
$841K 0.52%
15,629
– –
SO icon
42
Southern Company
SO
$109B
$803K 0.49%
17,687
– –
BRK.A icon
43
Berkshire Hathaway Class A
BRK.A
$1.1T
$760K 0.47%
4
– –
CBSH icon
44
Commerce Bancshares
CBSH
$8.53B
$735K 0.45%
28,389
– –
PAYX icon
45
Paychex
PAYX
$41.6B
$681K 0.42%
16,395
– –
GWW icon
46
W.W. Grainger
GWW
$65.3B
$435K 0.27%
1,711
– –
IBM icon
47
IBM
IBM
$211B
$392K 0.24%
2,259
-63
-3% -$11.3K
COP icon
48
ConocoPhillips
COP
$147B
$321K 0.2%
3,746
– –
MET icon
49
MetLife
MET
$61.9B
$297K 0.18%
6,003
– –
MCK icon
50
McKesson
MCK
$100B
$279K 0.17%
1,500
– –
1
2
3

Similar funds

TC
TAGStone Capital Charlotte, North Carolina $283M AUM 14.51% 1-Year Est. Return
UFAC
Urban Financial Advisory Corp Chicago, Illinois $283M AUM 13.45% 1-Year Est. Return
DIP
Davis Investment Partners Charlotte, North Carolina $283M AUM 24.98% 1-Year Est. Return
DRD
Dennis R. Delaney $282M AUM 16.32% 1-Year Est. Return
BO
Bank OZK Little Rock, Arkansas $283M AUM 24.45% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
CCM
Chaney Capital Management Lynnwood, Washington $284M AUM 15.54% 1-Year Est. Return
WP
Wealthspan Partners Davenport, Iowa $284M AUM 19.86% 1-Year Est. Return

Thomas Story & Son's Q2 2014 Portfolio in Review

As of Q2 2014, Thomas Story & Son held 63 positions worth $162M, down 12% from $184M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Thomas Story & Son withdrew a net $26.5M in Q2 2014, closing 7 positions and reducing 23 holdings. Its most notable exit was Idexx Laboratories, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Energy and Technology.

Against the trend, Thomas Story & Son opened a new position in Boardwalk Pipeline Partners worth $263K.

  • Thomas Story & Son's largest Q2 2014 buy was Boardwalk Pipeline Partners: 14,200 shares worth $263K.
  • Thomas Story & Son added most to Gentex in Q2 2014, an estimated $1.55M increase.
  • Thomas Story & Son's biggest Q2 2014 reduction was Praxair Inc, cutting an estimated $2.08M.
  • Thomas Story & Son fully exited Idexx Laboratories in Q2 2014, selling an estimated $2.23M.
  • Thomas Story & Son's ten largest holdings make up 46% of its $162M portfolio in Q2 2014.
  • Thomas Story & Son opened 1 new position and closed 7 in Q2 2014.
  • Thomas Story & Son's portfolio value fell 12% quarter-over-quarter to $162M.

Based on Thomas Story & Son's 13F filing for Q2 2014, filed 1 Aug 2014.